Navigation Links
System in brain -- target of class of diabetes drugs -- linked to weight gain
Date:5/1/2011

CINCINNATIUniversity of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-γ found in the brain) is also triggered by consumption of high-fat foods.

The study could lead to the modification of existing diabetes therapies and even dietary recommendations to limit the action of this nuclear receptor in the brain.

The research, led by Randy Seeley, PhD, UC professor and Donald C. Harrison Endowed Chair in Medicine, appears as an advanced online publication May 1, 2011, in the journal Nature Medicine.

PPAR-γ is found in white adipose (fat) tissue where it regulates the production of fat cells. This new research describes an important role for PPAR-γ in the brain.

PPAR-γ is the target of a class of diabetes drugs called TZDs (thiazolidinediones). This class of drugs reduces blood glucose levels but also causes considerable weight gain. That weight gain, Seeley says, makes many patients reluctant to use these therapies particularly since many are already trying to lose weight to improve their diabetes.

Seeley and his team set out to determine whether or not the brain's PPAR-γ system was responsible for the weight gain associated with TZDs. The team also wanted to learn if this system in the brain was activated by a high-fat diet.

To do so, they used animal models to test how the class of drugs interacted with the brain PPAR-γ system. They found that by giving TZD drugs in the same manner that people take them, rats gained weight. This was because the drugs activated PPAR-γ in the brain. Thus, weight gain associated with this class of drugs may not be a result of action of PPAR-γ in fat as had been previously thought, but rather a result of a change in activity in parts of the brain known to regulate appetite.

Seeley's team went on to also show that high-fat diets result in activation of the brain PPAR-γ system. Experiments in which the activity of the brain PPAR-γ system was limited resulted in less weight gain when animals were exposed to a high-fat diet similar to diets of many Americans.

"If you artificially turn on PPAR-γ, you can increase food intake in rats," says Seeley. "If you block these receptors in animals on high-fat diets that make animals obese, animals gain less weight."

In the past, says Seeley, people thought that the production of more fat cells in response to TZD drugs was the cause of the resulting weight gain, but he adds, "Just having more fat cells is not enough to make animals or people fatter. Rather you have to eat more calories than you burn and that is exactly what happens when you turn on the brain PPAR-γ system.

"This work helps us understand the complex relationship between our fat, our appetites and type 2 diabetes."

Fat cells are actually quite protective and act as safe repositories for excess nutrients that cause damage when stored in other tissues like the liver and muscle, says Seeley. "It's when nutrients are stored in these cells that individuals are at increased risk for metabolic diseases such as type 2 diabetes."

This, he says, is why TZDs are effective at lowering glucose. The extra fat cells produced become the storage containers for nutrients that would otherwise be harmful if they are stored in other areas of the body.

"You can think of your fat tissue like a bathtub," Seeley says. "A bathtub is designed to hold water. It's a good place to store it. If you turned on the faucet but didn't have a bathtub, the water would go to other parts of your house and cause water damage."

The same is true for nutrients, says Seeley. "It is better to store them in your fat tissue "bathtub" than to have them go to other parts of your body where they can do more harm."

Seeley says PPAR-γ is a system designed at all levels to help you prepare to eat more and gain weight opening up the possibility that food we eat that can activate PPAR-γ might contribute to increasing rates of obesity.

"It tells your brain to eat more and it tells your fat tissue to add new fat cells to serve as repositories to store those extra calories."

He says the next steps would be to find ways to redesign TZDs so that they retain their important glucose-lowering function but with less access to the brain, thereby limiting weight gain.

In the longer term, Seeley says, it's important to better understand the interaction between the brain's PPAR-γ system and the specific micronutrients we consume from fat, protein and sugar.

"We know that one way to activate PPAR-γ is by exposing cells to fatty acids. If we know which ones activate PPAR-γ, we could find ways to alter diets so as to limit their ability to turn on this system that drives increased food intake, making it easier for people to avoid weight gain."


'/>"/>

Contact: Dama Ewbank
dama.ewbank@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Source:Eurekalert

Related biology news :

1. UCSB urban ecosystem research featured in leading ecology journal
2. A tale of 2 lakes: One gives early warning signal for ecosystem collapse
3. RIKEN and Max Planck Society establish Joint Research Center for Systems Chemical Biology
4. Simple fungus reveals clue to immune system protection
5. Youku Upgrades Fingerprinting System for Tougher Copyright Protection Measures
6. Ahram Biosystems Announces Launch of the Palm PCR(TM) Portable PCR System
7. FDA approves the NovoTTF-100A system for the treatment of patients with recurrent glioblastoma multiforme (GBM) brain tumors
8. Death -- not just life -- important link in marine ecosystems
9. Stress wrecks intestinal bacteria, could keep immune system on idle
10. Common nanoparticles found to be highly toxic to Arctic ecosystem
11. A better understanding of the aging immune system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an integrated wealth management ... The Future of San Diego Life Science event at the Estancia La Jolla Resort ... the event with speakers Dr. Rich Heyman, former CEO of Aragon and Seragon, and ...
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
(Date:5/23/2016)... ... May 23, 2016 , ... Foresight Institute , ... the winners for the 2015 Foresight Institute Feynman Prizes. , These prestigious ... categories, one for experiment and the other for theory in nanotechnology. Prof. Markus ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A ... offer a new way to treat the disease. Surviving Mesothelioma has just posted an ... Scientists from several Korean institutions based their mesothelioma study on the fact the Manumycin ...
Breaking Biology Technology: